Express Pharma

API manufacturing finally getting the attention it deserves

While formulation generics flounders a bit, the data show that the Indian API industry has done better, with a five-year revenue CAGR of 15 per cent, and EBITDA margins consistently in the 24-28 per cent bracket

1 2,042